Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Stamaril and tetravalent dengue vaccine in healthy toddlers
2014-001714-26Phase 3
- Sponsor
- Sanofi
- Start
- May 2014
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of 17D yellow fever vaccine and CYD dengue vaccine in dengue fever and yellow fever (2 arms), sponsored by Sanofi. Primary endpoint: Yellow fever seroconversion rate.
02
Drugs
17D yellow fever vaccineCYD dengue vaccine
03
Conditions
dengue feveryellow fever
Beyond the preview
Go deeper on 2014-001714-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001714-26.